Literature DB >> 2786229

COVER (cover of vaccination evaluated rapidly): description of the England and Wales scheme.

N T Begg, O N Gill, J M White.   

Abstract

The COVER scheme, a method for the rapid evaluation of vaccine coverage in England and Wales, is described. The primary aim of the scheme is to improve cover by providing health district vaccination programme coordinators with relevant timely information. Quarterly data were obtained from, analysed and promptly fed back to, 126 health districts on cohorts of children who had recently attained the target ages for receiving the selected sentinel vaccines; 18 months for third diphtheria and third pertussis and 2 years for measles. Although the data suggested that vaccination cover is improving, national performance still falls well short of 90%, the 1990 target set by the World Health Organisation for countries in Europe.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2786229     DOI: 10.1016/s0033-3506(89)80021-6

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  10 in total

1.  Could an outbreak of poliomyelitis occur in the UK?

Authors:  D Brown; N Begg; B Wiratunga
Journal:  BMJ       Date:  1992-03-07

2.  Symptoms after accelerated immunisation.

Authors:  M E Ramsay; M Rao; N T Begg
Journal:  BMJ       Date:  1992-06-13

3.  Data on vaccine uptake should be checked.

Authors:  J N Rao
Journal:  BMJ       Date:  1992-04-25

4.  Health and social care service changes: the potential to increase inequalities.

Authors:  D A C Elliman; H Bedford
Journal:  Arch Dis Child       Date:  2006-10       Impact factor: 3.791

5.  Vaccine coverage in England: the impact of health service reorganisation.

Authors:  J Granerod; J M White; N Andrews; N S Crowcroft
Journal:  Arch Dis Child       Date:  2006-02-16       Impact factor: 3.791

6.  Idiopathic thrombocytopenic purpura and MMR vaccine.

Authors:  E Miller; P Waight; C P Farrington; N Andrews; J Stowe; B Taylor
Journal:  Arch Dis Child       Date:  2001-03       Impact factor: 3.791

7.  Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods.

Authors:  M E Ramsay; C P Farrington; E Miller
Journal:  Epidemiol Infect       Date:  1993-08       Impact factor: 2.451

8.  Monitoring childhood immunizations: a Canadian approach.

Authors:  J D Roberts; L A Poffenroth; L L Roos; J D Bebchuk; A O Carter
Journal:  Am J Public Health       Date:  1994-10       Impact factor: 9.308

9.  Vaccine coverage: recent trends and future prospects.

Authors:  J M White; S J Gillam; N T Begg; C P Farrington
Journal:  BMJ       Date:  1992-03-14

10.  The importance of tetanus risk assessment during wound management.

Authors:  Sarah Collins; Joanne White; Mary Ramsay; Gayatri Amirthalingam
Journal:  IDCases       Date:  2014-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.